SWAV ShockWave Medical
- 330.000
- +1.010+0.31%
ShockWave Medical News
Why the Market Dipped But Shockwave Medical (SWAV) Gained Today
Shockwave Medical (SWAV) Rose on an Acquisition News and Solid Financial Result
Shockwave Medical (SWAV) Advances While Market Declines: Some Information for Investors
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
On Tuesday, Johnson & Johnson delivered a rather mixed first quarter report.
Why Shockwave Medical (SWAV) Could Beat Earnings Estimates Again
Pharma Stock Roundup: JNJ to Buy Shockwave Medical, Other Pipeline & Regulatory News
Shockwave Medical (SWAV) Rose on Strong Financial Results
Shockwave Medical Opens IVL Production Plant in Costa Rica That Will Add 1,200 Jobs
Top 5 Non-Tech Nasdaq Winners of Q1 With More Upside Left
Does Johnson & Johnson's Latest Acquisition Make It a No-Brainer Buy?
Shockwave Medical Merges With Johnson & Johnson, Retains Key Leader
Shockwave Medical Has Positive Reducer Data
Shockwave Reducer Shows Promise in Angina Treatment
Shockwave Medical , Inc. (NASDAQ: NASDAQ:SWAV) announced today that recent data from the REDUCER-I trial presented at the American College of Cardiology's 73rd Annual Scientific Sessions in Atlanta, GA, points to positive outcomes for its Shockwave Reducer technology, aimed at treating refractory angina.
Shockwave Reducer Demonstrates Consistent, Positive Results in 'Real-World' Study
SANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular
Shockwave Medical, Inc. (NASDAQ:SWAV) Looks Just Right With A 30% Price Jump
Despite an already strong run, Shockwave Medical, Inc. (NASDAQ:SWAV) shares have been powering on, with a gain of 30% in the last thirty days. Looking back a bit further, it's encouraging to see th
Express News | CL King Downgrades Shockwave Medical to Neutral
Express News | Leerink Partners Downgrades Shockwave Medical to Market Perform, Lowers Price Target to $335
CL King Downgrades CL King to Neutral From Buy, Cuts Price Target to $335 From $368
ShockWave Medical (SWAV) has an average rating of hold and price targets ranging from $165 to $368, according to analysts polled by Capital IQ. Price: 326.26, Change: -0.08, Percent Change: -0.03
Shockwave Medical Price Target Raised to $335.00/Share From $270.00 by Deutsche Bank
Shockwave Medical Price Target Raised to $335.00/Share From $270.00 by Deutsche Bank
J&J's (JNJ) $13.1B Shockwave Deal to Boost MedTech Cardio
Analysis
Price Target
No Data
